Digital Diagnostics vs Eko Health
Two point of care diagnostics that both bypass the specialist, and only one of them bypasses the clinician too. Digital Diagnostics holds the strongest regulatory position in this index: an authorisation for autonomous diagnosis of diabetic retinopathy where the system issues the result and no physician reads the image, backed by the best pivotal evidence design here and with equity built into that design rather than appended to it. Eko puts cardiac detection inside the stethoscope, flagging low ejection fraction, atrial fibrillation and murmurs during an exam the clinician is already doing, with a decade of stacked clearances and a randomised trial behind it. The difference is who is accountable for the result. In one case a primary care clinic gets a diagnosis without a specialist. In the other it gets a reason to order the echocardiogram sooner.
- It is the only United States authorised instance of a diagnosis made without a clinician reading the image, which is the furthest point on this index's autonomy spectrum and the reason the product exists.
- The pivotal evidence design is the strongest in this index, and equity was an input to that design rather than a disclosure added afterwards.
- There is a reimbursement pathway for the workflow rather than a value argument, which matters more than any feature when a primary care clinic is deciding whether to run the test at all.
- A decade of stacked clearances, each tied to a specific stated indication, and the only record on this side of the index with a randomised trial behind it.
- It works inside an exam a clinician is already performing, analysing ECG and heart sound together from a stethoscope rather than requiring a separate imaging step.
- The reimbursement side is disclosed, which is the half of the economics most vendors leave a buyer to discover after purchase.
Side by Side
| Axis | D Digital Diagnostics |
E Eko Health |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Diagnostics & Genomics page.
The autonomy difference is the most important thing here and it changes what evidence you should demand. An autonomous diagnosis with no clinician in the loop needs pivotal evidence in the population and setting where it will run, which Digital Diagnostics has; a detection aid presented to a clinician needs to show that clinicians act better with it than without, which is what Eko's trial addresses.
Neither publishes a health privacy statement or business associate terms, and Digital Diagnostics publishes no security attestation of any kind. Eko publishes no subgroup or population performance analysis, which matters because heart sound and ECG characteristics vary with body habitus and sex.